Changes to the pharmaceutical industry over the last ten years, such as rising price pressures and increasingly complex drugs, have meant that contract service providers have seen an increase in demand for a full-service offering. This is in turn driving consolidation across the CDMO landscape.

Our CEO, Kevin Cook, speaks to Manufacturing Chemist about the current trends impacting the contract manufacturing space and what it takes to succeed as a CDMO in such a competitive marketplace. Read the full roundtable here: http://bit.ly/2ps4O5C.